Primary Immunodeficiency in Kuwait
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03618147|
Recruitment Status : Completed
First Posted : August 7, 2018
Results First Posted : September 4, 2019
Last Update Posted : September 9, 2019
- Background/Rationale: Epidemiological data about Primary Immunodeficiency Disorders (PIDD) in Kuwait is needed to better understand peculiarities and to compare them with other regions and ethnicity.
- Study hypothesis: PIDD is relatively common in Kuwait compared to populations from different geographic areas. The distribution of PIDD in Kuwait is different from other geographic areas with more severe forms being more frequent.
- Brief inclusion and exclusion criteria of study participants: PIDD patients presented at different clinics/hospital in Kuwait. Patients with secondary immunodeficiencies (drug induced, virus induced, and immunodeficiency associated with metabolic disorders... ect), will be excluded
- Estimated sample size of the study: All patients who were registered in KNPIDR since 2004 will be included in the study along with the new patients who will be recruited during the study period.
- Determine the prevalence and frequency of different PIDD in Kuwait
- Identify clinical presentation patterns for PIDD in Kuwait
- Identify natural history of PIDD in Kuwait
- Help to asses epidemiology of PIDD in Kuwait
- Determine particularities about PIDD affecting the population in Kuwait
- Determine the health impact of PIDD in Kuwait
- Development of strategies to improve the care and the quality of life of patients with PIDD
|Condition or disease|
|Primary Immune Deficiency Disorder|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||314 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Kuwait National Primary Immunodeficiency Registry (KNPIDR)|
|Actual Study Start Date :||July 16, 2018|
|Actual Primary Completion Date :||May 1, 2019|
|Actual Study Completion Date :||May 1, 2019|
- Number of Participants With Different Epidemiological Features [ Time Frame: 15 years ]
- Number of Overall and New Cases of PID Per 100,000 Kuwaitis [ Time Frame: 15 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03618147
|Pediatric Deprtmemt, Alsabah hospital|